These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19468799)

  • 1. Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
    Zhen YZ; Lin YJ; Shang BY; Zhen YS
    Int J Hematol; 2009 Jul; 90(1):44-51. PubMed ID: 19468799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.
    Zhen YZ; Lin YJ; Liu XJ; Shang BY; Zhen YS
    Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice.
    Zhen YZ; Lin YJ; Li Y; Zhen YS
    Acta Pharmacol Sin; 2009 Jul; 30(7):1025-32. PubMed ID: 19575006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway.
    Liu X; Bian C; Ren K; Jin H; Li B; Shao RG
    Oncol Rep; 2007 Mar; 17(3):597-603. PubMed ID: 17273739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The synergistic effect of lidamycin and rituximab on human B cell lymphoma].
    Sun YR; Zhang SH; Shao RG; He HW
    Yao Xue Xue Bao; 2014 Feb; 49(2):198-203. PubMed ID: 24761609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
    Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
    Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.
    Lee SA; Jung M
    J Biol Chem; 2007 May; 282(20):15271-83. PubMed ID: 17371872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
    Zhang C; Guo LY; Mu D; Gong JH; Chen J
    Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species-mediated activation of AMP-activated protein kinase and c-Jun N-terminal kinase plays a critical role in beta-sitosterol-induced apoptosis in multiple myeloma U266 cells.
    Sook SH; Lee HJ; Kim JH; Sohn EJ; Jung JH; Kim B; Kim JH; Jeong SJ; Kim SH
    Phytother Res; 2014 Mar; 28(3):387-94. PubMed ID: 23640957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
    Yang J; Chen SZ
    Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
    Hsu WH; Hsieh YS; Kuo HC; Teng CY; Huang HI; Wang CJ; Yang SF; Liou YS; Kuo WH
    Arch Toxicol; 2007 Oct; 81(10):719-28. PubMed ID: 17673978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair.
    Han FF; Li L; Shang BY; Shao RG; Zhen YS
    Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells.
    Wang Z; He Q; Liang Y; Wang D; Li YY; Li D
    Biochem Pharmacol; 2003 Jun; 65(11):1767-75. PubMed ID: 12781328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
    Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
    Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.
    Liu H; Li L; Li XQ; Liu XJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):41-9. PubMed ID: 19342999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes.
    Engelbrecht AM; Niesler C; Page C; Lochner A
    Basic Res Cardiol; 2004 Sep; 99(5):338-50. PubMed ID: 15309413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DC-81-enediyne induces apoptosis of human melanoma A375 cells: involvement of the ROS, p38 MAPK, and AP-1 signaling pathways.
    Chen CY; Chen YK; Wang JJ; Hsu CC; Tsai FY; Sung PJ; Lin HC; Chang LS; Hu WP
    Cell Biol Toxicol; 2013 Apr; 29(2):85-99. PubMed ID: 23292217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin.
    Assefa Z; Vantieghem A; Declercq W; Vandenabeele P; Vandenheede JR; Merlevede W; de Witte P; Agostinis P
    J Biol Chem; 1999 Mar; 274(13):8788-96. PubMed ID: 10085120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.